Xuemei H. Luo
321 Zhongshan Road
Nanjing, 210008, China
Nanjing, 210008, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Corrigendum: Population pharmacokinetics and dosing optimization of imipenem in Chinese elderly patients.
Journal: Frontiers in pharmacology
Published: January 24, 2025
Population pharmacokinetics and dose optimization of voriconazole in patients with COVID-19-associated pulmonary aspergillosis.
Journal: Frontiers in pharmacology
Published: January 02, 2025
Population pharmacokinetics and dosing optimization of imipenem in Chinese elderly patients.
Journal: Frontiers in pharmacology
Published: November 07, 2024
Predictive factors for 30-day mortality after polymyxin B treatment of carbapenem-resistant Gram-negative bacilli infections.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: October 21, 2024
A positive FOXP3/lncRNA SNHG1 feedback axis ameliorates cardiomyocytes hypertrophy by negatively regulating Parkin-mediated mitophagy.
Journal: International immunopharmacology
Published: March 12, 2024
Population pharmacokinetics, dosing optimization and clinical outcomes of biapenem in patients with sepsis.
Journal: Frontiers in pharmacology
Published: February 19, 2024
Case report and literature review: management of Paxlovid (nirmatrelvir/ritonavir)-induced acute tacrolimus toxicity in a patient with systemic lupus erythematosus.
Journal: Frontiers in pharmacology
Published: January 04, 2024
The pharmacokinetics/pharmacodynamics of ceftazidime/avibactam for central nervous system infections caused by carbapenem-resistant Gram-negatives: a prospective study.
Journal: The Journal of antimicrobial chemotherapy
Published: October 20, 2023
A descriptive pharmacokinetic/pharmacodynamic analysis of ceftazidime-avibactam in a case series of critically ill patients with augmented renal clearance.
Journal: Pharmacology research & perspectives
Published: August 22, 2023
Analysis of Factors Influencing Whole Blood Hydroxychloroquine Concentration in Patients with Systemic Lupus Erythematosus in China.
Journal: Rheumatology and therapy
Published: August 05, 2023
Mid-dosing interval concentration is important for polymyxin B exposure and acute kidney injury in critically ill patients.
Journal: CPT: pharmacometrics & systems pharmacology
Published: May 12, 2023
Pharmacokinetic/Pharmacodynamic Target Attainment of Tigecycline in Patients with Hepatic Impairment in a Real-World Setting.
Journal: Therapeutic drug monitoring
Published: February 20, 2023
Last Updated: 09/26/2026